Security key
04351P101
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 40,100,469
- Total 13F value
- $2,509,199,237
- Share change
- -133,467
- Put/Call ratio
- 15%
- SEC-reported price per share
- $62.65
- Number of holders
- 102
- Value change
- -$10,826,186
- Number of buys
- 42
- Number of sells
- 49
- Shares outstanding
- 62,915,156
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2018
Institutions
102
Top holders
10
ASND full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2019
Previous quarter: Q3 2018
Ascendis Pharma A/S SEC filings
Ascendis Pharma A/S company facts
Broader feeds
Reporting periods
Holder history for CUSIP 04351P101
Recent filing periods:
Ownership snapshot
Top reported holders of ASND - Ascendis Pharma A/S - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
RA CAPITAL MANAGEMENT, L.P.
Disclosed value leader
RA CAPITAL MANAGEMENT, L.P.
Comparable rows
15/15
Latest evidence
30 Sep 2018
13F
Lead comparable stake: 6.7%
Showing 1-6 of 15 holder rows.
Quick read
RA CAPITAL MANAGEMENT, L.P. leads the comparable SEC ownership view at 6.7%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens RA CAPITAL MANAGEMENT, L.P.'s linked filing trail.
Comparable ownership
Top 5
RA CAPITAL MANAGEMENT, L.P.
6.7%
ORBIMED ADVISORS LLC
6.6%
FMR LLC
6.6%
PRICE T ROWE ASSOCIATES INC /MD/
5.4%
BAKER BROS. ADVISORS LP
4.5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. |
13F
Company
|
6.7%
|
$300,484,000
4,240,536 shares
|
— | 30 Sep 2018 |
| ORBIMED ADVISORS LLC |
13F
Company
|
6.6%
|
$294,486,000
4,155,891 shares
|
— | 30 Sep 2018 |
| FMR LLC |
13F
Company
|
6.6%
|
$294,230,000
4,152,262 shares
|
— | 30 Sep 2018 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
5.4%
|
$239,634,000
3,381,796 shares
|
— | 30 Sep 2018 |
| BAKER BROS. ADVISORS LP |
13F
Company
|
4.5%
|
$201,055,000
2,837,352 shares
|
— | 30 Sep 2018 |
| Sofinnova Investments, Inc. |
13F
Company
|
3.9%
|
$175,698,000
2,479,514 shares
|
— | 30 Sep 2018 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2018
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
102
Shares
40,100,469
Rows available
102
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2018 vs Q3 2018 Across Filers
Q3 2018 holders
94
Q4 2018 holders
102
Holder diff
8
| Investor | Q3 2018 Shares | Q4 2018 Shares | Share Diff | Share Chg % | Q3 2018 value | Q4 2018 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend